pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Sep 8·1 min read
save

Anthropic hires corporate development lead to drive biopharma acquisitions and partnerships

Sep 8, 2026·read at Endpoints ↗DealPositive

Anthropic, the San Francisco AI company, posted a job for a corporate development lead focused on biopharma.

The role will involve sourcing and executing acquisitions, investments and strategic partnerships that blend AI with life-science research.

Hiring for this position underscores Anthropic's ambition to move into biotech, using its AI expertise to support drug discovery and development.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Expanding its biopharma plans, Anthropic looks for a life sciences dealmaker”

read at Endpoints ↗
91 words · retrieved Sep 8
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 10h agoMerck reports mixed data for Lucentis competitor in diabetic macular edemaEndpoints
  • 11h agoAsahi Kasei lands approval for new HSV treatmentEndpoints
  • 13h agoMirum succeeds in rare liver disease trial; First Tracks delivers in celiacEndpoints
  • 13h agoBristol Myers reveals a pair of Phase 3 wins for fibrosis, RayzeBio drugsEndpoints
  • 13h agoBrent Saunders out as Bausch + Lomb CEO, an abrupt end to three-year runEndpoints